Use of P53 silenced endothelial progenitor stem cells (hEPC) in diabetic peripheral vascular disease
Author Department
Medicine
Document Type
Presentations, Research
Publication Date
6-1-2011
Recommended Citation
Sen S, Young M, Jerry J. Use of P53 silenced endothelial progenitor stem cells (hEPC) in diabetic peripheral vascular disease. American Diabetes Association 71st Scientific Sessions. San Diego, CA. 2011.
COinS